Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction

被引:20
作者
Bär, F
Vainer, J
Stevenhagen, J
Neven, K
Aalbregt, R
Ophuis, TO
van Ommen, V
de Swart, H
de Muinck, E
Dassen, W
Wellens, H
机构
[1] Univ Hosp Maastricht, Dept Cardiol, NL-6202 AZ Maastricht, Netherlands
[2] Univ Limburg, Cardiovasc Res Inst Maastricht, Dept Physiol, NL-6200 MD Maastricht, Netherlands
[3] Maastricht Univ, Maastricht, Netherlands
[4] Canisius Wilhelmina Hosp, Nijmegen, Netherlands
关键词
D O I
10.1016/S0735-1097(00)00718-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE How effective and safe is rescue percutaneous transluminal coronary angioplasty [PTCA] compared with primary PTCA, and is it cost effective? BACKGROUND In acute myocardial infarction (AMI), primary PTCA has been shown to be beneficial in terms of clinical outcome. In contrast, the value of rescue PTCA has not been established. METHODS In a retrospective analysis, we compared the angiographic and clinical outcomes of 317 consecutive patients who had rescue PTCA similar to 90 min after failed thrombolysis and 442 patients treated with primary PTCA. An estimation of interventional costs was compared with tilt: strategies of primary and rescue PTCA or with the strategy of thrombolysis with rescue PCA, when indicated. RESULTS Baseline characteristics between primary and rescue PTCA were comparable for most variables. Treatment delay was longer for patients who had rescue PTCA: 240 min. versus 195 min. Coronary patency after PTCA was comparable: 90.2% for rescue PTCA and 91.4% for primary PTCA (p = 0.67, power 71.9%). In-hospital mortality rates were 4.7% and 6.6%, respectively (p = 0.37). Also, the other complications were fairly similar during the in-hospital phase and during one-year follow-up. Predictors of death were age, infarct size, localization of AMI, failed PTCA and left main stem occlusion. The estimated interventional costs during one-year follow-up were $7,377 for primary PTCA and $8,246 for rescue PTCA: difference $869 (11.7%). CONCLUSION In this retrospective analysis of 759 patients with AMI, rescue angioplasty early after failed thrombolysis seems to be as effective and safe as primary PTCA. In the present evaluation, interventional costs of primary PTCA are less than those of rescue PTCA (p = 0.0001). (J Am Coil Cardiol 2000;36:51-8) (C) 2000 by the American College of Cardiology.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 31 条
[21]   Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial) [J].
Miller, JM ;
Smalling, R ;
Ohman, EM ;
Bode, C ;
Betriu, A ;
Kleiman, NS ;
Schildcrout, JS ;
Bastos, E ;
Topol, EJ ;
Califf, RM .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (07) :779-784
[22]  
OUDE OAJ, 2000, IN PRESS HEART
[23]  
OUDE OAJ, 1999, AM HEART J, V137, P846
[24]   A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial [J].
Ross, AM ;
Coyne, KS ;
Reiner, JS ;
Greenhouse, SW ;
Fink, C ;
Frey, A ;
Moreyra, E ;
Traboulsi, M ;
Racine, N ;
Riba, AL ;
Thompson, MA ;
Rohrbeck, S ;
Lundergan, CF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (07) :1954-1962
[25]  
VandeWerf F, 1997, NEW ENGL J MED, V337, P1124
[26]   Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities:: a safety and feasibility study [J].
Vermeer, F ;
Ophuis, AJMO ;
van der Berg, EJ ;
Brunninkhuis, LG ;
Werter, CJ ;
Boehmer, AG ;
Lousberg, AH ;
Dassen, WR ;
Bär, FW .
HEART, 1999, 82 (04) :426-431
[27]   WHICH PATIENTS BENEFIT MOST FROM EARLY THROMBOLYTIC THERAPY WITH INTRACORONARY STREPTOKINASE [J].
VERMEER, F ;
SIMOONS, ML ;
BAR, FW ;
TIJSSEN, JGP ;
VANDOMBURG, RT ;
SERRUYS, PW ;
VERHEUGT, FWA ;
RES, JCJ ;
DEZWAAN, C ;
VANDERLAARSE, A ;
KRAUSS, XH ;
LUBSEN, J ;
HUGENHOLTZ, PG .
CIRCULATION, 1986, 74 (06) :1379-1389
[28]   RANDOMIZED TRIAL OF INTRAVENOUS RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR VERSUS INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].
VERSTRAETE, M ;
BORY, M ;
COLLEN, D ;
ERBEL, R ;
LENNANE, RJ ;
MATHEY, D ;
MICHELS, HR ;
SCHARTL, M ;
UEBIS, R ;
BERNARD, R ;
BROWER, RW ;
DEBONO, DP ;
HUHMANN, W ;
LUBSEN, J ;
MEYER, J ;
RUTSCH, W ;
SCHMIDT, W ;
VONESSEN, R .
LANCET, 1985, 1 (8433) :842-847
[29]  
Widdershoven JWMG, 1997, EUR HEART J, V18, P1073
[30]   A COMPARISON OF IMMEDIATE CORONARY ANGIOPLASTY WITH INTRAVENOUS STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].
ZIJLSTRA, F ;
DEBOER, MJ ;
HOORNTJE, JCA ;
REIFFERS, S ;
REIBER, JHC ;
SURYAPRANATA, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (10) :680-684